U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922383) titled 'A Clinical Study of Arfolitixorin in Patients With mCRC' on March 25.
Brief Summary: This is a clinical research study taking place in Germany. Patients with colorectal cancer at a stage of the disease where metastases occur may take part in the study. A maximum of 60 people will participate in the study.
There is already a standard therapy for treatment of colorectal cancer. This therapy contains a combination of the medicines leucovorin, fluorouracil, oxaliplatin and bevacizumab.
The sponsoring company is developing the new therapy called arfolitixorin. In this study, patients with colorectal cancer will be given arfolitixorin ...